Development of gene therapy to target pancreatic cancer.
about
A novel method for polymer coating of plasmid DNA: initial investigations into the use of pulse laser deposition and gene delivery.Oncolytic virus therapy for pancreatic cancer using the adenovirus library displaying random peptides on the fiber knob.Biological approaches to therapy of pancreatic cancer.Suppression of Tregs by anti-glucocorticoid induced TNF receptor antibody enhances the antitumor immunity of interferon-α gene therapy for pancreatic cancer.Optimizing DC vaccination by combination with oncolytic adenovirus coexpressing IL-12 and GM-CSF.Discovery and analysis of pancreatic adenocarcinoma genes using cDNA microarrays.Gene therapy progress and prospects: gene therapy for diabetes mellitus.Adenovirus-mediated interferon alpha gene transfer induces regional direct cytotoxicity and possible systemic immunity against pancreatic cancerMolecular mechanisms of pancreatic cancer and potential targets of treatment.Oncolytic adenovirus coexpressing interleukin-12 and shVEGF restores antitumor immune function and enhances antitumor efficacy.Morphologic manifestations of gene-specific molecular alterations ("genetic addictions") in mouse models of disease.Strengthening of antitumor immune memory and prevention of thymic atrophy mediated by adenovirus expressing IL-12 and GM-CSF.LPA1 receptors mediate stimulation, whereas LPA2 receptors mediate inhibition, of migration of pancreatic cancer cells in response to lysophosphatidic acid and malignant ascites.Combined silencing of K-ras and Akt2 oncogenes achieves synergistic effects in inhibiting pancreatic cancer cell growth in vitro and in vivo.Local interferon-alpha gene therapy elicits systemic immunity in a syngeneic pancreatic cancer model in hamster.Antisense Smo under the control of the PTCH1 promoter delivered by an adenoviral vector inhibits the growth of human pancreatic cancer.Oncolysis of pancreatic tumour cells by a gamma34.5-deleted HSV-1 does not rely upon Ras-activation, but on the PI 3-kinase pathway.Optimized ultrasound-mediated gene transfection in cancer cells.
P2860
Q33208316-08B84FC8-F107-4979-A43D-29E67EE2AB3CQ33410245-4100D1DF-A257-4D61-A406-3013CC6A88AAQ33899938-4162734D-BFA1-4258-A642-BC2B5E21E526Q35051508-48B1651B-6289-4D32-B358-5832319F371CQ35144428-76F3861D-F40A-45D6-8198-DCDF696DED53Q35166017-F4A0F6EF-F2DB-41A1-AD5E-9BAC06F9F892Q35924387-1944C3E8-B7DB-424F-A9E2-2A7B4A3993E6Q36615168-66D2DD62-EB64-4D39-A054-E15353076083Q36758436-96C67887-60B5-48F0-9E33-6DDBC0EFAD41Q37709052-56C9812B-BD52-43E9-96F5-79839B7E3BD5Q37968973-20B553CB-2076-476F-8D39-9BF74B9A3C0AQ39459281-06E52EF0-9C51-4574-818C-05A909E13953Q39897898-8A6D6288-5132-4220-9B7D-8B9AAECFDCACQ39925886-5F09A77C-B966-4260-AF33-695AEA6751F3Q40181994-FCD03127-7D46-46C8-9C31-1A9FE1D67D3CQ40257960-B691BA5A-D774-4137-AE54-9E2B4F1313AAQ40300876-105A8714-B57D-457D-ABA4-364FF0BBD115Q45861946-539CCF5A-AB17-4A1D-94F5-249C2AD83960
P2860
Development of gene therapy to target pancreatic cancer.
description
2004 nî lūn-bûn
@nan
2004 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Development of gene therapy to target pancreatic cancer.
@ast
Development of gene therapy to target pancreatic cancer.
@en
type
label
Development of gene therapy to target pancreatic cancer.
@ast
Development of gene therapy to target pancreatic cancer.
@en
prefLabel
Development of gene therapy to target pancreatic cancer.
@ast
Development of gene therapy to target pancreatic cancer.
@en
P2093
P2860
P1433
P1476
Development of gene therapy to target pancreatic cancer.
@en
P2093
Kazunori Aoki
Shumpei Ohnami
Teruhiko Yoshida
P2860
P304
P356
10.1111/J.1349-7006.2004.TB03204.X
P577
2004-04-01T00:00:00Z